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Encephalopathy in a 14-Year-Old Boy with Leukemia in 
Remission
Tallie Z. Baram Margaret G. Normanb
aM.D. Anderson Hospital and Tumor Institute, Houston, Tex., USA; bDepartment of Pathology, University of British Columbia, 
Vancouver, Canada
Clinical History
This boy was well until the age of 12 years when he developed a 
cough. A month later he was treated with antibiotics for fever, 
anorexia and vomiting without improvement. A film of peripheral 
blood showed blast cells. Examination on admission showed him to 
be tired and unwell. Hemoglobin was 10.9 g/% , white blood cell 
count (WBC) 10,800/pl w'ilh 7% polymorphs. 7% stab cells, 80% 
lymphocytes and 6% blasts, and platelet count was 154,000/pl. Ex­
amination of the bone marrow showed a marked infiltrate of blast 
cells. Of the blast cells 95% were positive for common acute lym­
phoblastic leukemia (ALL) antigen. His cerebrospinal fluid (CSF) 
contained 20 erythrocytes (RBC)/pl and 6 WBC/pl, but no blast 
cells. He received the following induction chemotherapy: vincristine,
2 mg i.v. 4 times weekly; daunomycin, 35 mg i.v. 4 times weekly; L- 
asparaginase, 8,400 U i.m. for 9 doses; prednisone, 30 mg 3 times 
daily for 28 days, and intrathecal methotrexate 12 mg twice. He did 
not receive cranial irradiation. He tolerated the chemotherapy well; 
by day 14 his bone marrow was in remission, and by 28 days, hypocel- 
lular. He was treated with intravenous cloxacillin and gentamicin for 
fever. When various cultures were negative antibiotics were stopped.
He had low back pain due to osteoporosis and slight collapse of 
the end plates of L, and L-. vertebrae. He passed a renal calculus at­
tributed to bone demineralization secondary to prednisone. Consoli­
dation therapy consisted of cyclophosphamide, 1,350 mg for 2 doses, 
6-mercaptopurine (6-MP), 80 mg daily for 27 days, Ara-C, 100 mg 
s.c. 4 times a week for 4 weeks, and intrathecal methotrexate weekly.
Over the next 2 years he was maintained on 6-MP, vincristine, 
prednisone and intrathecal methotrexate every 3 months. Several epi­
sodes of neutropenia and thrombocytopenia resulted in his 
chemotherapy being withheld for short periods of time. His bone 
marrow remained in remission. His CSF was normal. Several epi­
sodes of infection required treatment with antibiotics.
Thirty months after the diagnosis of leukemia was made, and
3 months before his last admission, he was admitted with cough 
productive of yellow sputum, fever and vomiting. He had been con­
tinued on 6-MP and intrathecal methotrexate. His temperature was 
39.8 °C, and he looked unwell. Chest X-ray showed a widespread in­
terstitial pneumonia. WBC was 1,800/pl with neutrophils 1,296/pl, 
band cells 198/pl, lymphocytes 99/pl, monocytes 72/pl, eosino­
phils 99/pl, metamyelocytes 18/pi, and atypical lymphs 18/pl.
Hemoglobin was 13.5 g/% , and platelet count 79,000/pl. His serum 
was tested for antibodies to various viruses, including measles, and 
all were negative. A lung biopsy showed Pneumocystis carinii. Septra 
was increased, and he was continued on ampicillin and gentamicin. 
He was discharged home, but readmitted a few days later.
He was then hospitalized for 2 weeks because of fever, neutrope­
nia and an intermittent scaly skin rash, which did not look like 
measles. Measles were present in the community. Chemotherapy had 
been withheld for 10 days prior to this admission because of neu­
tropenia. Physical examination showed a red pharynx and a few 
petechiaeon the soft palate. Chest X-ray showed increased interstitial 
markings. Treatment with gentamycin, cloxacillin and Bactrim did 
not improve his state, so he was treated with cefuroxime, amantadine 
and amphotericin. He became afebrile and was discharged.
Several days later he was readmitted with a high, spiking fever and 
dry cough. Investigations showed only a mild persisting interstitial 
pneumonitis. A bone marrow aspiration showed 1% blast cells. He 
was pancytopenic. A second lung biopsy was performed. The lung bi­
opsy showed a nodular interstitial pneumonitis, with scarring, ob­
literation of the air spaces, nodules of proliferating bronchiolar lin­
ing cells, macrophages and a few polymorphonuclear leukocytes. 
Multinucleate giant cells were present. Stains for organisms and elec­
tron microscopy failed to show any microorganisms or viral inclu­
sions. Cultures for virus were negative. He was discharged after a few 
days.
His last admission was for persistent respiratory problems. The 
patient had been cooperative previously; several days after his admis­
sion he was rude and uncooperative. Three days later he became con­
fused and reported ‘a girl stealing Fruit Loops’ and could subtract 
serial 7s only to 86. He had oral candidiasis. His WBC was 3,200/pl 
and hemoglobin 10.1 g/%. A spinal tap 2 days after the onset of his 
confusion showed that the CSF was under normal pressure, clear and 
colorless. Measles antibody titers for IgG and IgM in the CSF were 
negative. The protein was 36 mg/dl, glucose 26 mg/dl, RBC 1/pl, 
and nucleated cells 0. He was treated with an intravenous infusion of 
gamma globulin. Over the next few days he made inappropriate com­
ments, was confused, slow and anorexic. Then one leg twitched 
repeatedly through the morning. He became disoriented and had lit­
tle memory of the events of the previous few days. These were consi­
dered as possible episodes of myoclonus. The patient reported twitch- 
ings of the right lower leg, which he could suppress only with great 
difficulty.
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He had a fever of 38.5 °C. EEG showed a disorganized back­
ground, occasional multifocal sharp waves, including polyspike dis­
charges and epileptiform discharges. Focal lesions were not evident 
on computed tomography (CT) scan, although global tissue loss was 
noted. There was no improvement despite therapeutic doses of 
diphenylhydantoin. Six days after he was first confused he became 
drowsy.
Ten days after the onset of confusion he complained of a burning 
sensation in the right eye and vomited several times. The next day he 
developed generalized, multifocal, myoclonic jerking of the legs, 
right arm and head. He complained of pain in the right ear. He was 
drowsy but coherent. The next day, all four limbs twitched uncon­
trollably. He was conscious and oriented, but not appropriately upset 
about the twitching. He tried to hold a cup of tea although his twitch­
ing was too great to do so. He was treated with interferon, 20 MU 
daily for 4 weeks. Two weeks after he first became confused he was 
drowsier, his speech was slurred but coherent. He was oriented to 
place but not to date, and was so drowsy that his memory could not be 
tested. Myoclonic jerking was improved, but both feet twitched. He 
was on diphenylhydantoin, 150 mg twice daily, and Ativan as re­
quired. He was drowsier. He had epilepsia partialis continua.
Three weeks later he developed a morbilliform, maculopapular, 
erythematous rash over the legs, feet and back; it w'as scant over the 
arms. The differential diagnosis was drug rash or measles-like rash. It 
was not a classical rubeola rash. A month after onset of neurological 
symptoms he had his first generalized tonic-clonic seizure. He cried 
out for help, and started twitching. A patchy, acute, superficial retini­
tis was resolving. The retina showed only minor pigmentary abnor­
malities.
Five weeks after the onset of neurological symptoms he became 
unresponsive. The only response to painful stimuli was vague open­
ing of the eyes and increase in respiratory rate. Pupils were round, 
equal and symmetrical, eyes conjugate, and eye movements roving 
and full, with no nystagmus. He was hypotonic with decreased deep 
tendon reflexes and upgoing plantar responses. He developed conges­
tive heart failure and was treated with digoxin. He was febrile and 
dusky, with increasing densities in the right lower and right middle 
lobes, and had air hunger. Septra was increased.
He was transferred to the intensive care unit. He was treated with 
erythromycin and placed on a respirator. He was given dopamine, sa­
line and plasma intravenously, to support his blood pressure.
The retinitis showed healing areas, but also new acute lesions. 
Hemoglobin was 9.9 g/%  (after transfusion), platelets 57,000/pI, 
WBC 10,400/pl with lymphocytes 600/pl. He was maintained with 
continuous positive airway pressure.
Seven weeks after the onset of neurological symptoms he was 
comatose. Both arms tw'itched independently. This was described as 
multifocal seizures, epilepsia partialis continua and myoclonic jerks. 
He was unresponsive to deep pain. Pupils were 2-3 mm and reacted 
sluggishly. Eye movements were full, and corneal reflexes were 
present. There was no response to suctioning, all limbs were flaccid, 
tendon reflexes were depressed and plantars showed no response. He 
was on a respirator, but breathing spontaneously, with improved 
cardiorespiratory function.
He was extubated and transferred back to the ward, where he was 
maintained on anticonvulsants, antibiotics, oxygen and total paren­
teral nutrition. He had occasional right-sided seizures. He developed 
various complications, including a decubitus ulcer, hypernatremia 
attributed to hyperaldosteronism, congestive heart failure and
hypocalcemia. About 2 months after the onset of neurological symp­
toms he developed further deterioration in his lung function, with de­
velopment of rales, rhonchi and decreased air entery in the right side. 
It was decided that no further therapy was warranted except palliative 
care. Death occurred almost 3 months after onset of neurological 
symptoms.
Investigations: lgG290 mg/dl (normal 750-2,000), IgA 32 mg/dl 
(normal 84-483), IgM 19 mg/dl (normal 63-250). IgGintheCSF was 
1.7 ng/dl. Viral serology 4 days and 2 weeks after the administration 
of gamma globulin showed the IgG to be measles-positive, the IgM 
negative; this was considered to be passively acquired antibody due to 
the administration of gamma globulin.
The mother did not know whether the boy had had measles im­
munization, and could not find this out despite persistent ques­
tioning.
Discussion: Dr. T.Z. Baram
This case presentation deals with a subacute neuro­
logical deterioration in a 14-year-old boy 2 years after 
the diagnosis of ALL. In summary, having been found 
to have ALL, this young gentleman received the accept­
ed treatment for leukemia: induction (with vincristine, 
daunomycin, /.-asparaginase, prednisone and intrathe­
cal methotrexate); consolidation (with Cytoxan, 6-MP, 
Ara-C); intrathecal methotrexate for central nervous 
system (CNS) prophylaxis and maintenance (6-MP, vin­
cristine and prednisone).
We are told of several of the not uncommon compli­
cations of leukemia and its treatment, such as osteopo­
rosis with a mild compression of L, and L: vertebrae, as 
well as neutropenia, thrombocytopenia and infections. 
Specifically absent from the case presentation is infor­
mation about the administration of blood transfusions.
The case presentation becomes more detailed 
3 months prior to the youngster’s last admission, when 
he presented with yellow sputum, fever and vomiting, 
had an interstitial pneumonitis diagnosed as P. carinii, 
for which he was treated. Subsequent episodes of fever 
and neutropenia with an unusual scaly skin rash and 
soft palate petechiae followed, with a questionable 
responsiveness to the combination of cefuroxime, am­
photericin B and amantadine. During the subsequent 
admission for interstitial pneumonitis, open-lung biop­
sy was performed.
His neurological deterioration is detailed in the 
description of his last admission. That consisted of a 
personality change, specifically rudeness, confusion 
and hallucinations, followed by a movement disorder, 
probably myoclonus, with an abnormal EEG and 
atrophy on CT scan. Over 2 months his neurological
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status declined with drowsiness, dementia and worsen­
ing of the myoclonus. Terminally, he was unresponsive 
with normal pupils, full eye movements, hypotonia and 
extensor plantar responses; diffuse multifocal myoclo­
nus is described. Throughout the last month of his 
illness he had a retinitis. Decompensation of cardiac 
and pulmonary functions with a probable superim­
posed infection occurred, to which the youngster suc­
cumbed.
In short, a youngster with leukemia, suffering the ef­
fects of the disease and its treatment, undergoes 
progressive neurological deterioration over a 3-month 
course, resulting in death.
In discussing possible causes for our patient’s neuro­
logical deterioration, several issues need to be consi­
dered: the effects of ALL per se on the CNS; the direct 
effects of drugs used for its treatment, and the indirect 
effects of therapy, i.e. the presence of an immunocom­
promised state.
The patient was in remission, with no malignant cells 
in his CSF, and had received CNS prophylaxis. It is thus 
unlikely that he had CNS leukemia. Moreover, CNS 
leukemia usually manifests the effects of meningeal in­
volvement, and increased intracranial pressure was not 
seen in our patient [1].
It is unlikely also that the subacute neurological 
decline of the patient was due to chemotherapy. Vin­
cristine usually causes peripheral neuropathy, but has 
well-documented CNS effects on humans, in animal 
studies and on neurons in vitro [2-4], ¿-Asparaginase 
has been associated with stroke-like episodes [5]. High 
doses of Ara-C result in cerebellar ataxia as well 
as diffuse, global neurological dysfunction [6,7]. 
Methotrexate, used either in high doses systemically, or 
intrathecally, has been shown to result in acute stroke­
like episodes with hemiplegia, seizures and aphasia [8, 
9]. Methotrexate has also been associated with subacute 
deterioration in mental status and diffuse global dys­
function [8, 10].
These toxic effects are acute and immediate and un­
likely to occur as late in the course as our patient was; 
however, long-term effects of chemoprophylaxis for 
CNS leukemia merit consideration [11, 12]. These, more 
common with radiation therapy but seen with intrathe­
cal methotrexate alone, present as a subacute leukoen- 
cephalopathy (e.g. confusion, lethargy, ataxia, spastici­
ty) [12, 13]. Unlike the findings with subacute leukoen- 
cephalopathy [14], our patient’s CT revealed only 
cerebral atrophy, found in 16% of children given in­
trathecal methotrexate [15].
Throughout his illness, our patient had fever, with 
clinical and pathological evidence for several infections. 
ALL and its treatment cause an immunocompromised 
state. Thus, youngsters on therapy for ALL have a sus­
ceptibility to a host of opportunistic organisms. Bacteri­
al infections, notoriously Pseudomonas, Klebsiella and 
Escherichia coli, usually run an acute fulminant course 
[16]. The CNS is involved directly or indirectly (as a 
result of anemia, hypoxia or sepsis) [16, 17], This pa­
tient’s prolonged, gradual deterioration does not sug­
gest an acute bacterial infection. Rarely, a subacute or 
chronic course is seen with unusual bacterial disease, 
such as CNS Whipple, described in immunocom­
promised patients with AIDS [18], Its manifestations in­
clude movement disorders, such as the myoclonus seen 
in our patient [18]; however, prominent dysfunction of 
ocular motility, absent in this case, has been a persistent 
finding in CNS Whipple [18, 19].
This patient’s immunodeficiency, antibiotic treat­
ment and chronic course of fever and CNS decline are 
compatible with a fungal infection. Oral candidiasis 
was present during his last admission. Candida has re­
cently emerged as the most common fungal CNS infec­
tion in the immunocompromised host [16, 20]. A recent 
review [20] suggests that the CNS is involved in 50% of 
systemic Candida infections, yet this CNS involvement 
is rarely suspected or proved antemortem. The neuro­
logical involvement and manifestation of Candida can 
be protean and can fit with this patient’s course. Still, 
CNS candidiasis is usually associated with fulminant 
systemic disease [20], and the absence of Candida on 
lung biopsy would be unusual. Other ncurotropic fun­
gal infections such as cryptococcosis and actinomycosis 
would have been detected on CSF studies and/or lung 
biopsy [21].
Protozoal parasites infect immunocompromised 
hosts, specifically, P. carimi and Toxoplasma gondii [22]. 
The former, isolated from the patient’s lungs, only rare­
ly invades the CNS [16]; toxoplasmosis results in a 
necrotizing encephalitis and, commonly, typical ocular 
involvement, not present in this case [16].
We are left with a viral infection, which I consider as 
the most likely etiology for this patient’s course.
Prior to discussing the host of viruses which may in­
volve the CNS in the immunocompromised host, a 
review of some of the clues provided by the case presen­
tation may be indicated. Fever, a morbilliform rash and 
palatal petechiae are nonspecific; the lung biopsy find­
ings and the retinitis are more helpful. The lung biopsy 
revealed airway obliteration, interstitial pneumonitis
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and multinucleated giant cells. The latter had been 
described as typical for measles infection by Hecht in 
1910 [23], Very few other organisms, notably respiratory 
syncytial virus, can create this pathological appearance 
[J.M. Bruner, pers. commun.]. The absence of viral in­
clusions does not rule out a measles pneumonia.
Superficial patchy retinitis has been described with 
numerous viruses [26], The large herpesviruses, namely 
cytomegalovirus (CMV), herpes simplex and varicella- 
zoster, as well as the measles virus may cause lesions 
with identical funduscopic and histologic appearance 
[26]. Retinitis is commonly the presenting feature of 
subacute sclerosing panencephalitis (SSPE) and occurs 
at some point in 50% of patients [25, 26]. The presence 
of both healing and new lesions is very typical of SSPE 
[R. Lewis, pers. commun.]. The retinopathies of con­
genital measles virus, progressive measles infection and 
SSPE may be indistinguishable [24], Thus, the lung 
findings and, to some degree the funduscopic examina­
tion, as well as the rash, may suggest infection with 
measles virus.
Measles virus infection in the human can result in 
three types of infections. The most common, in an im­
munocompetent host, is the familiar acute disease, with 
Koplik’s spots, fever, coryza and rash. Rarely, this may 
be followed by a measles encephalitis. In the im­
munocompromised host, an ‘atypical’ infection has 
been reported, with an acute or a subacute course as­
sociated with progressive involvement of lung and CNS 
[23,27,28]. Atypical measles with encephalitis is seen in 
children with leukemia [27-29] and lymphoma, com­
monly in remission [27, 28], or other chronic illnesses 
[28], Measles infection precedes the neurological 
deterioration by weeks to 6 months; the latter is charac­
terized by personality changes [27,29], seizures [27,28], 
commonly myoclonic seizures [30, 31] or epilepsia par­
tialis continua [29], declining mental status and death 
[27-31]. The course simulates an accelerated version of 
that of SSPE [28]. Neurologic dysfunction can be acute, 
with death occurring within a week of presentation [28], 
but more commonly is subacute, with death 4-10 weeks 
after onset [29-31]. CSF and serum IgG and measles 
titers in these immunodeficient patients are unpredic­
table: of 11 patients mentioned in these series [23, 
27-31] in whom CSF and/or serum measles titers were 
obtained, only 5 were positive. The criteria for the diag­
nosis of progressive measles encephalitis are: measles 
infection in an immunocompromised host, followed 
by progressive encephalopathy, in conjunction with 
demonstration of measles virus (by immunofluores­
cence, electron microscopy or culture) on biopsy or au­
topsy.
The third type of human involvement with measles 
virus is associated with a remote infection, usually in in­
fancy, followed years later by neurological deterioration 
with personality change, dementia, myoclonic seizures, 
coma and death. This SSPE is caused by a ‘defective’ 
measles virus demonstrable on brain biopsy or autopsy 
[32], The clinical course of SSPE has been exhaustively 
reviewed [20, 33], The initial presentation is that of mild 
intellectual deterioration and personality changes with 
progression of myoclonic seizures. Neurological impair­
ment is progressive, resulting in profound dementia, 
spasticity, bulbar signs, cortical blindness, and, finally, 
a vegetative state. The EEG is characteristic with syn­
chronous paroxysmal bursts of 2-3/s high-voltage, 
diphasic spike waves [33, 34], The background may be 
normal early, but slowing and suppression bursts are 
seen at a later stage. Atypical and even normal (early) 
EEGs are not uncommon [34],
CSF and serum usually reveal high elevated IgG [33] 
measles titers. SSPE usually results in death years after 
onset, but marked variation, including an acute, cata­
strophic course, has been reported [35],
In the immunocompromised host, the two separate 
entities of SSPE and progressive measles encephalitis 
(PME) may blend [28], In fact, several patients, first 
reported as having SSPE, were reclassified as having 
PME [28]. Titers are unhelpful in the immunodeficient 
[27-31]; the classical cellular reaction (perivascular 
cuffing) typical for the SSPE brain may be missing [23, 
28], The clinical course and EEG findings may be quite 
similar.
Murphy and Yunis [28] suggest that the two entities 
be separated on the basis of the remoteness of initial in­
fection (years versus weeks), immunocompetency and 
rapidity of clinical course.
I think our patient had measles virus involvement of 
skin, lungs, retinae and CNS. The absence of measles 
antibodies early in the course suggests his susceptibility 
to such an infection and the seroconversion after gam­
ma globulin administration is not helpful. Clinically, his 
course is more compatible with PME than SSPE, and, 
as mentioned, the pathological findings on brain autop­
sy may be identical [23, 28]. One may predict the 
presence of measles antigens on immunofluorescence, 
inclusion bodies on light microscopy and the typical 
microtubular nuclear aggregates on electron microsco­
py [23],
For completeness sake, several acute and subacute
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viral infections need to be mentioned. The herpesviruses 
are common; herpes simplex may cause retinitis, inter­
stitial pneumonitis and an acute encephalitis; varicella- 
zoster, while responsible for life-threatening pneumo­
nia, does not seem to have a greater predilection for the 
CNS in the immunocompromised versus a competent 
host [36], Meningoencephalitis, absent in this case, is 
usually seen [37], CMV, while showing a predilection 
for immunodeficient patients, causing interstitial pneu­
monitis, retinitis and encephalitis [36], can usually be 
easily cultured from lung biopsy, CSF and urine.
Progressive multifocal leukoencephalopathy is 
usually seen in immunosuppressed adults [38]. The un­
derlying organism is a papovavirus [39], CT and autop­
sy reveal patchy white matter destruction [38]; the CT 
findings and age of our patient make him an unlikely 
candidate for this entity.
Human immunodeficiency virus (HIV; HTLV-III) 
has emerged as a major neurotropic virus [40, 41]. 
Among the groups at risk for the infection are blood 
transfusion recipients, which may include our patient. 
Subacute encephalopathy with personality change, de­
mentia and long tract signs has been described in both 
children [41, 42] and adults [40]. While multinucleated 
giant cells have been found in brains infected by HIV 
[43, 44], they have not been described in the lung [45]. 
Furthermore, the retinal findings of AIDS include cot­
tonwool spots and usually the finding of other oppor­
tunistic organisms (e.g. CMV and Toxoplasma) [46,47], 
HIV titers are not reported for this patient, but this virus 
alone would not account for his clinical presentation.
Thus, I would attribute this patient’s illness to 
progressive measles infection.
Finally, the dogma of ‘one patient - one diagnosis’ 
may apply to the immunocompetent host. Our patient, 
like the majority of immunodeficient hosts, may have 
harbored two or several concurrent opportunistic or­
ganisms which contributed to his demise.
Diagnosis: progressive measles infection of im­
munocompromised host.
Discussion of Pathological Findings:
Dr. M.G. Norman
At autopsy the brain weighed 1,290 g (normal 
1,440 g). The only abnormality on gross examination 
was slight enlargement of the lateral ventricles with 
blunting of the corners of the lateral angles. Microscop­
ic examination showed lesions scattered through the
gray matter, mostly in cerebral cortex, with a few in basal 
ganglia, thalamus, brain stem and cerebellum. These 
varied from necrosis of individual neurons with a sur­
rounding ring of microglia to somewhat larger areas of 
neuronal loss, scant microglial reaction and astrocyto- 
sis. In some of these foci Cowdry’s type A inclusions 
(fig. 1) were found. In the most severely affected areas 
there was also some spongy change. In some of these 
foci, the walls of the vessels were thickened with a few 
mononuclear inflammatory cells (fig. 2), but infiltrates 
of plasma cells and lymphocytes in the parenchyma were 
absent. The curved tubules characteristic of paramyxo­
virus were found in the brain using electron microscopy. 
There were no lesions in the white matter, nor was there 
demyelination. Examination of the eyes showed a mild 
uveitis, migration of pigment from the retinal pigment 
epithelium, diminution of peripheral ganglion cells and 
some foci of loss of the inner nuclear layer as well 
[J. Rootman, pers. commun.]. Electron microscopy 
showed the typical curved tubules of paramyxovirus in 
the retina (fig. 3).
The immediate cause of death was a severe acute 
bronchopneumonia superimposed on a chronic intersti­
tial pneumonitis with irregular scarring.
The lymphoid tissue in the lymph nodes, thymus and 
bowel was depleted with only the reticular framework of 
the thymus persisting. Germinal centers were absent in 
the lymph nodes and bowel, and it was difficult to find 
plasma cells, although a few were present. The marrow 
was still in remission, but mature polymorphs were 
depleted, presumably reflecting migration into the acute 
pneumonia.
About 6 months after this boy died another similar 
case occurred. A 10-year-old boy with ALL in remission 
developed an encephalopathy and died. His disease last­
ed only 1 month. Clinically, it began with difficulty us­
ing words; he developed inability to control tempera­
ture, hypernatremia and hypertension, as well as demen­
tia, seizures and coma. His serum measles antibody titer 
was never greater than 1:10. It was known that he had 
had measles immunization, though not at what age. 
Although the cerebral cortex was patchily involved, the 
most damaged part of the brain was the hypothalamus 
and thalamus, as might have been predicted from his 
clinical symptoms.
One of the most striking things in these two cases was 
how little perivascular inflammation was present, in 
comparison to the usual cases of SSPE. In SSPE there 
are usually many mononuclear inflammatory cells with 
abundant plasma cells. It is only in the burned-out cases
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Fig. 1. Cérébral cortex. Cowdry’s type A inclusion in nucléus of 
astrocytes. Hcmatoxylin-eosin. x 500.
of SSPE, which have lasted for many years, that inflam­
matory cells are scant. It is the numerous plasma cells in 
the cerebral tissue which result in the high CSF measles 
antibody titers in SSPE.
Gray matter only was affected in our two patients. 
Cowdry’s type A inclusions were present in astrocytes in 
involved foci, but there was no involvement of white 
matter, nor any inclusions in oligodendrocytes, as can be 
seen in SSPE. Whether this indicates any difference in 
etiopathogenesis between measles in immunosup- 
pressed individuals [sometimes called ‘measles inclu­
sion body encephalitis’ (MIBE) or ‘subacute inclusion 
body encephalitis’ in the immunodeficient individual], 
or merely reflects the more acute course of MIBE is not 
known.
The lack of measles antibodies reflects the immune 
suppression. In both our cases the lymphoid tissue was 
scant, and only after careful search could any plasma 
cells be found in lymph nodes, gut and spleen. Since 
1959, the failure of children with leukemia in remission 
with measles giant cell pneumonia to mount an anti­
body response has been known [48]. The first cases of 
MIBE were reported in 1973 by Breitfeld et al. [23]. 
Kipps et al. [49] tabulated the 22 cases of MIBE report­
ed by 1983. Of 15 patients in whom serum measles anti­
body titers were assayed, 8 had antibody levels of less 
than 1:10. The commonest associated disease tabulated 
by Kipps et al. [49] was ALL; other diseases were 
chronic diarrhea, ganglioneuroma, neuroblastoma, 
lymphosarcoma, rhabdomyosarcoma and renal trans-
Fig. 2. Cerebral cortex. This illustrates maximum degree of 
mononuclear inflammation. Cells are in vessel wall rather than in 
surrounding parenchyma. Hematoxylin-eosin. x 100.
Fig. 3. Retina. Curved tubules characteristic of paramyxovirus. 
Formalin-fixed. Postfixed in giutaraldehyde. x 152,000. (Kindness of 
Eva Chan. C.L. Dolman, and J. Rootman.)
plantation. Graham et al. [50] described a case in an 
adult with hypogammaglobulinemia.
For many years the variable clinical picture of SSPE 
has been well known. Risk and Haddad [35] emphasized 
the varying natural history of the disease. Kipps et al. 
[49] tried to separate four CNS syndromes associated 
with measles: acute measles due to direct invasion of the 
CNS by virus or an allergic encephalomyelitis, delayed 
acute encephalitis with immunosuppression, delayed 
acute encephalitis without immunosuppression, and
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delayed subaeute encephalitis (SSPE). In view of the 
protean clinical manifestations of SSPE it is hard to 
make a distinction between the delayed acute encephali­
tis without immunosuppression and SSPE clinically. 
Pathologically both are characterized by the presence 
of Cowdry’s type A inclusions at the light-microscopic 
level, and paramyxovirus particles electron-micro- 
scopically. Probably the degree of damage to gray and 
white matter, particularly the degree of demyelination, 
and the amount of inflammation reflect how long the 
disease has been present and do not afford a morpho­
logical basis to separate delayed acute encephalitis 
without immunosuppression from SSPE.
A great advance in our understanding of SSPE came 
with the work of Choppin et al. [51]. They reported the 
absence of antibody to the M protein of the virus. The 
M protein is an internal membrane protein which plays 
a key role in the assembly of the virus particle by bud­
ding from the plasma membrane. It interacts with 
glycoproteins inserted in the cell membrane and the viral 
nucleocapsid.
One of the long-standing disputes about SSPE is 
whether it is due to a defective or mutant virus, or to a 
defect in the host’s immunity. Hall and Choppin [32] in­
terpreted their data to indicate that SSPE was due to a 
host-cell-dependent lack of synthesis of M protein, and 
was not due to a defective virus. In 1986, Cattaneo et al. 
[52] described a strain of SSPE virus in which ‘the nor­
mal, monocistronic M mRNA was completely substitut­
ed by a bicistronic RNA containing the coding sequence 
of the preceding phosphoprotein (P) gene in addition to 
the M-coding sequence. Analysis of the intercistronic P- 
M region by direct cDNA sequencing showed that the 
consensus sequence at this RNA processing site was un­
altered but revealed several different point mutations. 
cDNA cloning and sequencing of the entire M-coding 
region established that one of the point mutations leads 
to a stop codon at tripet 12 of the M-reading frame.’ 
These workers go on to state that it is still not settled 
whether the genetic defects are stable genetic alterations 
of replicating viral genomes or whether the genetic 
defects are imposed by the immune response restricting 
viral functions by unknown mechanisms.
Roos et al. [53] described a patient with MI BE in an 
immunosuppressed host whose serum produced trace 
precipitation to P and L proteins of the measles virus 
and no precipitation of M protein on electrophoresis. 
They interpreted their data to indicate the ‘MlBE is 
an opportunistic defective measles virus in the im­
munosuppressed.’
In neither of our cases were we able to culture measles 
virus by ordinary methods; true also of the case reported 
by Rooset al. [53]. Culture of the measles virus from pa­
tients with SSPE requires cocultivation, which may 
prove to be true of MI BE. The lack of M protein in one 
case of MI BE, and the inability to culture measles by or­
dinary means in those instances where the measles virus 
infection occurs in an immunosuppressed host may be 
further suggestive evidence that a defective measles vi­
rus is involved.
The diagnosis of Ml BE in life may be difficult, par­
ticularly in those cases where measles antibodies are 
low. The presence of epilepsia partialis continua in the 
setting of an immunodeficient individual, particularly a 
child, with the characteristic EEG findings of unilateral 
or bilateral high-amplitude slow waves and periodic 
lateralizing epileptiform discharges should lead to a 
high level of suspicion of the diagnosis [54], Brain biop­
sy is a possibility, but in both our cases the involvement 
of cortex was so focal and patchy, it would have been 
easy to take a biopsy from a perfectly normal-appearing 
area and thus fail to make the diagnosis.
At present, there is no known treatment for SSPE or 
MIBE. Simpson and Eden [55] reported the case of a 
4-year-old boy with ALL in remission, who developed 
an encephalopathy following an attenuated measles 
vaccine. The boy’s deterioration was halted when he was 
treated with interferon. Our patient did not respond to 
interferon, which was similar to the two cases treated 
with interferon by Olding-Stenkvist et al. [56]. Patho­
logical diagnosis: MIBE in an immunocompromised 
host.
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